<DOC>
	<DOCNO>NCT02297347</DOCNO>
	<brief_summary>Newborn screen early treatment prevent severe manifestation phenylketonuria ( PKU ) . However , executive function deficit , attention deficit disorder , slow processing speed , visual-motor problem commonly occur . Many adult disorder also suffer depression anxiety . In study investigator examine adult PKU sapropterin dihydrochloride ( Kuvan ) treatment PKU compare result subject PKU Kuvan . Using magnetic resonance imaging ( MRI ) technique , include novel MR spectroscopy ( MRS ) investigator hope discover distinct constellation deficit occur PKU . Adult subject PKU undergo comprehensive MRI evaluation , include novel method MR spectroscopy determine brain phenylalanine level . In addition , participant receive neurological neuropsychological examination dietary evaluation .</brief_summary>
	<brief_title>PKU Kuvan Imaging Study</brief_title>
	<detailed_description />
	<mesh_term>Phenylketonurias</mesh_term>
	<criteria>Adult classic PKU currently Kuvan treatment least one month . Age 1855 year Medical Records available include blood phenylalanine level first 6 year life . Capable provide informed consent Able undergo MRI procedures without sedate medication Does metal implant , brace , permanent retainer . Mild PKU mild hyperphenylalaninemia Less 18 year old great 55 year old No medical record available first 6 year life Not capable provide informed consent Not able undergo MRI without sedate medication Has metal implant , brace permanent retainer Currently involve clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>